Cat. No.: DIA-0230507
Product Information | |
---|---|
CAS No. | 16673-34-0 |
Formula | C16H17ClN2O4S |
Molecular Weight | 368.84 |
SMILES | COC1=CC=C(Cl)C=C1C(=O)NCCC2=CC=C(C=C2)[S](N)(=O)=O |
Product Description | NLRP3 Inflammasome Inhibitor I, an intermediate substrate in the synthesis of glyburide which is free of the cyclohexylurea moiety involved in insulin release, is a novel inhibitor of the NLRP3 inflammasome. |
Format & Storage | |
---|---|
Purity | > 98% |
Shipping | Shipped on dry ice. |
Storage | Powder: -20 °C, 3 years; 4 °C, 2 years In solvent: -80 °C, 6 months; -20 °C, 1 month |
Solubility Overview | Soluble in DMSO |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.